Translation of the Cancer Genome

February 7-9, 2015
The Fairmont San Francisco
San Francisco, California

Conference Co-Chairpersons
William C. Hahn, Dana-Farber Cancer Institute, Boston, Mass.
Lynda Chin, The University of Texas MD Anderson Cancer Center,
  Houston, Texas
William R. Sellers, Novartis Institutes for Biomedical Research,
  Cambridge, Massachusetts


Prepare for the conference with access to impactful genomics and systems biology articles, published across the AACR journals.

International efforts to characterize cancer genomes now provide a draft of the genetic, epigenetic and proteomic landscapes in human cancers. As such studies continue, the integration of this information with systematic functional studies will provide novel opportunities to transform cancer research and impact the care of patients. This AACR Special Conference will focus on new innovations to accelerate the translation of genomic insights, appealing to basic, translational, computational and clinical scientists from both academia and industry.

One of the conference highlights is a unique day of sessions and networking held jointly with the AACR Special Conference on Computational and Systems Biology of Cancer. Presenters will explore new directions in these overlapping and rapidly evolving fields to promote new opportunities for transdisciplinary collaborations. Attendees may register for one or both conferences.

Attendees of the AACR Special Conference on Translation of the Cancer Genome (A) will joined by the attendees of the AACR Special Conference on Computational and Systems Biology of Cancer (B) for a keynote address and reception on Sunday, Feb. 8, then for joint sessions on Monday, Feb. 9. During the joint sessions, overlapping themes in the areas of patient stratification, big data, and network-based cancer biology will be discussed to enhance interaction between colleagues across both disciplines.

Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available